SMCI faces securities class action over alleged export-control violations, compounding existing legal and operational risks

What happened

A securities fraud class action has been filed against Super Micro Computer, alleging the company misrepresented revenue derived from sales that may have violated U.S. export controls. The lawsuit covers purchasers of SMCI securities between April 30, 2024 and March 19, 2026, the same period during which the company disclosed an SEC subpoena and saw its co-founder charged in a separate criminal smuggling case. This litigation adds another layer of legal overhang to a business already struggling with extreme customer concentration (63% from one hyperscaler), compressed gross margins (6.4% non-GAAP), and $10.6 billion in inventory that strains cash flow. The company's Q2 FY2026 operating cash flow was negative $24 million, and it has drawn $0 on a $2 billion revolver, but the underlying economics remain weak: high revenue growth has not translated into sustainable profitability. The November 2026 trial date for the criminal case and ongoing control weaknesses mean the legal and compliance burdens will persist, further limiting the stock's upside potential.

Implication

Investors should view this class action as another reason to avoid or reduce exposure to SMCI, as it formalizes the revenue-related risks flagged in the DeepValue report. The suit does not change the fundamental drivers of the investment case: exaggerated customer concentration, structurally weak margins, and working-capital-intensive growth. Near-term catalysts—such as Q3 FY2026 revenue guidance of at least $12.3 billion—offer only temporary relief if gross margins fail to improve and cash flow remains negative. The legal proceedings (both criminal and civil) could extend customer diligence cycles and increase compliance costs, pushing the already-weak margins lower. Until we see concrete evidence of margin recovery above 7.5% and positive operating cash flow, the stock should trade closer to our bear-case value of $22, implying further downside from current levels.

Thesis delta

The lawsuit does not alter our thesis but reinforces the view that SMCI's legal and governance risks are material and likely underappreciated. The class action adds a new avenue for shareholder losses that may distract management and amplify the uncertainty already priced into the stock. No change to our POTENTIAL SELL rating; we continue to see downside risk toward our bear case of $22.